SCHEMBL8253104

SCHEMBL8253104

CC(C)(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NC(CC1CC1)C(=O)C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 2/20 0.47
▸ CTSV O60911 1/20 0.47
▸ CTSL P07711 1/20 0.47
▸ CTSB P07858 1/20 0.47
▸ CMA1 P23946 1/20 0.47
▸ CTSS P25774 1/20 0.47
▸ CTSK P43235 1/20 0.47
▸ CTSF Q9UBX1 1/20 0.47
▸ DPP4 P27487 3/20 0.45
▸ DPP8 Q6V1X1 2/20 0.45
▸ DPP9 Q86TI2 2/20 0.45
▸ FAP Q12884 1/20 0.45
▸ DPP7 Q9UHL4 1/20 0.45
▸ OPRM1 P35372 2/20 0.42
▸ XIAP P98170 1/20 0.40
▸ OPRD1 P41143 1/20 0.39
▸ OPRK1 P41145 1/20 0.39
▸ KMT2A Q03164 1/20 0.38
▸ CAPN1 P07384 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8247440 0.97 ELANE (0.50) ELANECTSVCTSLCTSBCMA1
SCHEMBL8282149 0.87 ELANE (0.54) ELANECTSVCTSLCTSBCMA1
SCHEMBL12601319 0.87 DPP4 (0.45) ELANECTSVCTSLCTSBCMA1
SCHEMBL8256866 0.86 DPP4 (0.41) ELANECTSVCTSLCTSBCMA1
SCHEMBL8240265 0.85 DPP4 (0.39) ELANECTSVCTSLCTSBCMA1
SCHEMBL12605574 0.84 ELANE (0.65) ELANECTSVCTSLCTSBCMA1
SCHEMBL8283743 0.84 ELANE (0.57) ELANECTSVCTSLCTSBCMA1
SCHEMBL12600879 0.83 ELANE (0.54) ELANECTSVCTSLCTSBCMA1
SCHEMBL12605573 0.83 CMA1 (0.50) ELANECTSVCTSLCTSBCMA1
SCHEMBL8252898 0.83 DPP4 (0.46) ELANECTSVCTSLCTSBCMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730110-B9 SULFUR COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORP (US) 2011-11-02 — — EP disclosed
EP-1730142-B1 NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS SCHERING CORP (US) 2011-06-29 — — EP disclosed
EP-1939213-B1 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORP (US) 2010-08-25 — — EP disclosed
WO-2006130553-A2 HCV PROTEASE INHIBITORS SCHERING CORPORATION (US) 2006-12-07 — — WO disclosed
WO-2006130628-A2 COMBINATION OF HCV PROTEASE INHIBITORS WITH A SURFACTANT SCHERING CORPORATION (US) 2006-12-07 — — WO disclosed
WO-2005085242-A1 NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS SCHERING CORPORATION (US) 2005-09-15 — — WO disclosed
Send feedback